Sarcopenia and Sarcopenic Obesity in Postmenopausal Women: Limitations of BMI as a Predictor of Sarcopenic Obesity.
4 affiliations
- 1Department of Endocrinology Diabetes and Metabolism, Christian Medical College Vellore India.
- 2Department of Biochemistry Christian Medical College Vellore India.
- 3Department of Biostatistics Christian Medical College Vellore India.
- 4Center for Stem Cell Research, Christian Medical College Vellore India.
Abstract
Objectives
The study aimed to assess the prevalence of sarcopenia and sarcopenic obesity among community-dwelling postmenopausal women. It also examined predictors of these conditions and their association with bone fragility.Methods
The cross-sectional study included 300 community-dwelling ambulant postmenopausal women aged 50 years or older recruited over 2 years. All participants underwent assessment of body mass index, bone mineral density, and body composition by dual-energy X-ray absorptiometry. Sarcopenia was diagnosed as per the Asian Working Group for Sarcopenia (AWGS) criteria. Sarcopenic obesity was defined as the presence of low muscle mass (relative appendicular skeletal mass-RASM < 5.4 kg/m²) and increased total fat mass% > 40%.Results
The mean (SD) age and body mass index of the participants were 61.9 (6.8) years and 25.3 (4.8) kg/m², respectively. Sarcopenia and sarcopenic obesity were identified in 43.7% and 27% of participants, respectively, while 48% had osteoporosis at any site. Although fat mass percentage was lower in those with sarcopenia, multivariable analysis adjusted for age, body mass index, and bone density identified higher fat mass percentage (aOR 1.715, p < 0.001) and lower body mass index (aOR 0.279, p < 0.001) as independent predictors. Receiver operating characteristic (ROC) analysis demonstrated good discrimination for body mass index (AUC 0.894) and modest discrimination for fat mass percentage (AUC 0.652); a combined model using body mass index and fat mass percentage improved prediction substantially (AUC 0.946). For sarcopenic obesity, lower body mass index (aOR 0.913, p = 0.010) and higher age (aOR 1.057, p = 0.010) were significant predictors.Conclusion
Sarcopenia and sarcopenic obesity were prevalent among community-dwelling postmenopausal women, with lower body mass index identified as a significant predictor of both conditions. The observation that low body mass index predicts both sarcopenia and sarcopenic obesity highlights the limitations of body mass index as a measure of adiposity when assessing sarcopenic obesity in postmenopausal women.
Related
- Defining Sarcopenic Obesity in the Asian Working Group for Sarcopenia 2025 Era: Diagnostic Precision Matters
- Urinary organophosphate flame retardants and risk of sarcopenia and sarcopenic obesity among middle-aged and older adults: a systematic investigation integrating epidemiological and adverse outcome pathway analyses
- Defining Sarcopenic Obesity in the Asian Working Group for Sarcopenia 2025 Era: Diagnostic Precision Matters ― Reply ―
- GLP-1 Receptor Agonists for Obesity Management in Older Adults: A Scoping Review on the Risk of Sarcopenia and Sarcopenic Obesity
- Impact of the Updated Asian Working Group for Sarcopenia 2025 Criteria on the Prevalence and Clinical Characteristics of Sarcopenic Obesity in Older Patients With Heart Failure
BibTeX
@article{rajan2026sarcopenia,
title = {{Sarcopenia and Sarcopenic Obesity in Postmenopausal Women: Limitations of BMI as a Predictor of Sarcopenic Obesity.}},
author = {Remya Rajan and Kripa Cherian and Thomas Paul and Hesarghatta Shyamasunder Asha and Arun Jose and Grace Rebekah and Nihal Thomas and Nitin Kapoor},
journal = {Aging medicine (Milton (N.S.W))},
year = {2026},
month = oct,
doi = {10.1002/agm2.70120},
url = {https://europepmc.org/article/MED/42928822},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Sarcopenia and Sarcopenic Obesity in Postmenopausal Women: Limitations of BMI as a Predictor of Sarcopenic Obesity.
AU - Remya Rajan
AU - Kripa Cherian
AU - Thomas Paul
AU - Hesarghatta Shyamasunder Asha
AU - Arun Jose
AU - Grace Rebekah
AU - Nihal Thomas
AU - Nitin Kapoor
PY - 2026
DA - 2026/10/25
JO - Aging medicine (Milton (N.S.W))
DO - 10.1002/agm2.70120
UR - https://europepmc.org/article/MED/42928822
AB - Objectives The study aimed to assess the prevalence of sarcopenia and sarcopenic obesity among community-dwelling postmenopausal women. It also examined predictors of these conditions and their association with bone fragility.Methods The cross-sectional study included 300 community-dwelling ambulant postmenopausal women aged 50 years or older recruited over 2 years. All participants underwent assessment of body mass index, bone mineral density, and body composition by dual-energy X-ray absorptiometry. Sarcopenia was diagnosed as per the Asian Working Group for Sarcopenia (AWGS) criteria. Sarcopenic obesity was defined as the presence of low muscle mass (relative appendicular skeletal mass-RASM < 5.4 kg/m²) and increased total fat mass% > 40%.Results The mean (SD) age and body mass index of the participants were 61.9 (6.8) years and 25.3 (4.8) kg/m², respectively. Sarcopenia and sarcopenic obesity were identified in 43.7% and 27% of participants, respectively, while 48% had osteoporosis at any site. Although fat mass percentage was lower in those with sarcopenia, multivariable analysis adjusted for age, body mass index, and bone density identified higher fat mass percentage (aOR 1.715, p < 0.001) and lower body mass index (aOR 0.279, p < 0.001) as independent predictors. Receiver operating characteristic (ROC) analysis demonstrated good discrimination for body mass index (AUC 0.894) and modest discrimination for fat mass percentage (AUC 0.652); a combined model using body mass index and fat mass percentage improved prediction substantially (AUC 0.946). For sarcopenic obesity, lower body mass index (aOR 0.913, p = 0.010) and higher age (aOR 1.057, p = 0.010) were significant predictors.Conclusion Sarcopenia and sarcopenic obesity were prevalent among community-dwelling postmenopausal women, with lower body mass index identified as a significant predictor of both conditions. The observation that low body mass index predicts both sarcopenia and sarcopenic obesity highlights the limitations of body mass index as a measure of adiposity when assessing sarcopenic obesity in postmenopausal women.
SN - 2475-0360
ER -